次のパンデミックインフルエンザウイルスは?

The development and genetic diversity of H5N1 influenza virus in China, 1996-2006.

Virology·2008

Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses.

Journal of virology·2007

Spread of H5N1 avian influenza virus: an ecological conundrum.

Letters in applied microbiology·2006

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Nature·2004

An update on avian influenza in Hong Kong 2002.

Avian diseases·2003

The impact of a monthly rest day on avian influenza virus isolation rates in retail live poultry markets in Hong Kong.

Avian diseases·2003

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

From Points to Landscapes: Measuring and Scaling Up Methane Emissions From Mound-Building Termites.

Global change biology·2026

Anthropogenic perturbations to atmospheric methane reflected in Greenland firn air clumped isotope measurements.

Science advances·2026

Who Pays the Heat Debt? Ethics, Labour, and Governance in a Warming World.

Bioethics·2026

Time series analysis of carbon dioxide emission: a comparison of statistical, machine learning, and deep learning models.

Environmental science and pollution research international·2026

Estimated HIV cases and costs in South Africa due to global warming from 2000 to 2050: a modeling study.

Scientific reports·2026

PeGLK1-1 Enhances Photosynthesis by Promoting Carbon Fixation Capacity of the Calvin Cycle in Bamboo.

Plant, cell & environment·2026

関連する実験動画

次のパンデミックインフルエンザウイルスは?

関連する概念動画

The development and genetic diversity of H5N1 influenza virus in China, 1996-2006.

Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses.

Spread of H5N1 avian influenza virus: an ecological conundrum.

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

An update on avian influenza in Hong Kong 2002.

The impact of a monthly rest day on avian influenza virus isolation rates in retail live poultry markets in Hong Kong.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

From Points to Landscapes: Measuring and Scaling Up Methane Emissions From Mound-Building Termites.

Anthropogenic perturbations to atmospheric methane reflected in Greenland firn air clumped isotope measurements.

Who Pays the Heat Debt? Ethics, Labour, and Governance in a Warming World.

Time series analysis of carbon dioxide emission: a comparison of statistical, machine learning, and deep learning models.

Estimated HIV cases and costs in South Africa due to global warming from 2000 to 2050: a modeling study.

PeGLK1-1 Enhances Photosynthesis by Promoting Carbon Fixation Capacity of the Calvin Cycle in Bamboo.

関連する実験動画

次のパンデミックインフルエンザウイルスは?

関連する概念動画

関連記事